Phase I/II study of first-line irinotecan combined with 5-fluorouracil and folinic acid Mayo Clinic schedule in patients with advanced colorectal cancer
Pre-publication versions of this article are available by contacting email@example.com.
|16 Jan 2004||Submitted||Original manuscript|
|11 Feb 2004||Reviewed||Reviewer Report - Ewald Woell|
|27 Feb 2004||Reviewed||Reviewer Report - Halfdan Sorbye|
|26 Mar 2004||Author responded||Author comments - thomas kuehr|
|Resubmission - Version 2|
|26 Mar 2004||Submitted||Manuscript version 2|
|6 Apr 2004||Reviewed||Reviewer Report - Halfdan Sorbye|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|14 Jul 2004||Author responded||Author comments - thomas kuehr|
|Resubmission - Version 4|
|14 Jul 2004||Submitted||Manuscript version 4|
|16 Jul 2004||Editorially accepted|
|16 Jul 2004||Article published||10.1186/1471-2407-4-36|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.